Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,000
Closed -$420K 51
2021
Q3
$420K Sell
1,000
-1,500
-60% -$112K 0.13% 36
2021
Q2
$568K Buy
+2,500
New +$167K 0.16% 40

Other funds holding HOLX

Tamarack Advisers's HOLX Position: Q2 2022 in Review

Tamarack Advisers sold out of Hologic (HOLX) in Q2 2022, closing a stake of 15,000 shares — an estimated $1.15M sold.

Tamarack Advisers first reported a position in HOLX in Q2 2016 and held it in 17 quarters. The position peaked at $24.6M in Q4 2019. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Tamarack Advisers reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Tamarack Advisers sold 15,000 Hologic shares in Q2 2022, an estimated $1.15M.
  • Tamarack Advisers first reported a position in Hologic in Q2 2016 and held it in 17 quarters.
  • Tamarack Advisers's Hologic position peaked at $24.6M in Q4 2019.
  • 695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Tamarack Advisers's 13F filing for Q2 2022, filed 16 Aug 2022.